Verastem, Inc., (NASDAQ:VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that Jose Baselga, M.D., Ph.D., has been named Senior Medical Advisor to the company.
“Research to develop new therapies targeting cancer stem cells is very exciting,” said Jose Baselga, M.D., Ph.D., Verastem Senior Medical Advisor and Physician-in-Chief at Memorial Sloan-Kettering Cancer Center. “The clinical deployment of these agents represents a potential new tool for physicians to use in the treatment of patients with aggressive and therapy-resistant cancers.”
Help employers find you! Check out all the jobs and post your resume.
